Sale!

DMD/BMD Mutation Screening 26 Exons Prenatal

Original price was: $350.Current price is: $262.

-25%

The DMD/BMD Mutation Screening 26 Exons Prenatal test is a comprehensive genetic screening designed to detect mutations in the dystrophin gene responsible for Duchenne and Becker muscular dystrophy. This advanced prenatal test analyzes 26 specific exons of the DMD gene using multiplex end-point PCR technology to identify deletions and duplications that cause these serious neuromuscular disorders. The test is recommended for pregnant women with family history of muscular dystrophy or those carrying known DMD gene mutations. Early detection allows for informed family planning decisions and appropriate medical management. Results are typically available within 4-5 days, providing timely information during pregnancy. The test is priced at $262 USD with a regular price of $350 USD, making comprehensive genetic screening accessible to families across the United States.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

DMD/BMD Mutation Screening 26 Exons Prenatal Test

Comprehensive Prenatal Genetic Screening for Muscular Dystrophy

The DMD/BMD Mutation Screening 26 Exons Prenatal test represents a critical advancement in prenatal genetic diagnostics, specifically designed to detect mutations in the dystrophin gene that cause Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD). This sophisticated screening provides expecting parents with essential information about their baby’s genetic health, enabling informed decisions and early intervention planning.

What This Test Measures and Detects

This comprehensive prenatal screening utilizes advanced Multiplex End Point PCR technology to analyze 26 specific exons of the DMD gene, which is located on the X chromosome. The test specifically targets:

  • Deletion mutations in the dystrophin gene
  • Duplication events affecting gene function
  • Point mutations within critical coding regions
  • Genetic variations associated with DMD and BMD

The dystrophin gene is the largest known human gene, spanning approximately 2.4 million base pairs, and mutations in this gene lead to progressive muscle degeneration and weakness characteristic of both Duchenne and Becker muscular dystrophy.

Who Should Consider This Prenatal Screening

This specialized prenatal test is particularly recommended for:

  • Pregnant women with a family history of Duchenne or Becker muscular dystrophy
  • Women known to be carriers of DMD gene mutations
  • Couples with previous children diagnosed with muscular dystrophy
  • Families with unexplained muscle weakness or elevated creatine kinase levels
  • Women with abnormal ultrasound findings suggesting muscle abnormalities

Clinical Benefits of Early Detection

Early identification of DMD/BMD mutations through prenatal screening offers numerous advantages:

  • Enables informed reproductive decision-making
  • Facilitates early intervention and treatment planning
  • Provides opportunity for specialized medical care coordination
  • Allows for genetic counseling and family planning
  • Reduces diagnostic uncertainty and anxiety
  • Supports preparation for potential healthcare needs

Understanding Your Test Results

Test results are carefully analyzed and interpreted by our team of certified genetic counselors and medical geneticists. Your report will include:

  • Clear identification of any detected mutations
  • Interpretation of mutation significance and clinical implications
  • Risk assessment for disease development
  • Recommendations for follow-up testing if needed
  • Genetic counseling referral information

Negative results indicate no mutations were detected in the 26 exons screened, while positive results will specify the exact mutation identified and its clinical significance.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $262
Regular Price $350

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified collection centers ensures accessible genetic testing services nationwide.

Sample Collection and Processing

This prenatal test requires specialized sample collection performed by qualified healthcare professionals:

  • Sample Type: Amniotic fluid, Chorionic villi, or Cord blood
  • Turnaround Time: 4-5 days
  • Test Components: Sterile container, Sterile Normal Saline Container, EDTA Vacutainer (2ml)

Pre-Test Requirements

A doctor’s prescription is required for DMD/BMD mutation screening prenatal testing. Please note that prescriptions are not applicable for surgery and pregnancy cases or individuals planning to travel abroad.

Book Your Prenatal Genetic Screening Today

Take the first step toward comprehensive prenatal genetic health assessment. Our experienced genetic counselors are available to discuss your testing options and answer any questions you may have about DMD/BMD mutation screening.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your appointment or learn more about our comprehensive prenatal genetic testing services.

Early detection through advanced genetic screening provides valuable information for your family’s health journey. Trust our expertise in genetic diagnostics to deliver accurate, reliable results with the compassionate care you deserve.